美股A股
StockGist
Back
8-K2026-02-12· deepseek-chat

INDP · Indaptus Therapeutics, Inc.

0001493152-26-006330

SEC filing

Summary

Indaptus Therapeutics entered into warrant repricing agreements on February 11, 2026, reducing the exercise price of certain warrants to $1.75 per share and securing voting commitments from holders for an upcoming special stockholder meeting. This action adjusts existing financing terms and aligns shareholder votes on key proposals.

Key takeaways